Difference between revisions of "Lin W, et al. Biomed. Res. Int. (2019) cited as Ref 623 in DOI: 10.1038/s41392-020-0110-5 (Q9886)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 2019, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Mesenchymal stem cells and cancer: clinical challenges and opportunities, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Mesenchymal stem cells and cancer: clinical challenges and opportunities (English) | ||
| Property / title: Mesenchymal stem cells and cancer: clinical challenges and opportunities (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Lin W, et al. Biomed. Res. Int. (2019) cited as Ref 623 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Lin W
0 references
2019
0 references
Biomed. Res. Int.
0 references
2019
0 references
Mesenchymal stem cells and cancer: clinical challenges and opportunities (English)
0 references
